- Home
- DRS vs HALO Comparison
DRS vs HALO Comparison
Compare DRS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRS
- HALO
- Stock Information
- Founded
- DRS 1969
- HALO 1998
- Country
- DRS United States
- HALO United States
- Employees
- DRS N/A
- HALO N/A
- Industry
- DRS Military/Government/Technical
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRS Industrials
- HALO Health Care
- Exchange
- DRS Nasdaq
- HALO Nasdaq
- Market Cap
- DRS 8.3B
- HALO 7.4B
- IPO Year
- DRS N/A
- HALO N/A
- Fundamental
- Price
- DRS $41.67
- HALO $52.02
- Analyst Decision
- DRS Buy
- HALO Buy
- Analyst Count
- DRS 6
- HALO 9
- Target Price
- DRS $38.33
- HALO $63.56
- AVG Volume (30 Days)
- DRS 1.1M
- HALO 3.1M
- Earning Date
- DRS 05-01-2025
- HALO 05-06-2025
- Dividend Yield
- DRS 0.43%
- HALO N/A
- EPS Growth
- DRS 25.90
- HALO 55.40
- EPS
- DRS 0.88
- HALO 3.76
- Revenue
- DRS $3,345,000,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- DRS $9.55
- HALO $24.79
- Revenue Next Year
- DRS $6.15
- HALO $22.65
- P/E Ratio
- DRS $47.35
- HALO $13.83
- Revenue Growth
- DRS 13.58
- HALO 25.64
- 52 Week Low
- DRS $21.98
- HALO $41.28
- 52 Week High
- DRS $42.62
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- DRS 67.49
- HALO 39.78
- Support Level
- DRS $40.01
- HALO $47.50
- Resistance Level
- DRS $43.20
- HALO $69.94
- Average True Range (ATR)
- DRS 1.59
- HALO 3.52
- MACD
- DRS -0.07
- HALO -1.49
- Stochastic Oscillator
- DRS 79.35
- HALO 19.64
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.